日本語
EnglishPay Attention to the Extraordinary Shareholders’ Meeting of Takeda Pharmaceutical
There shall be an extraordinary shareholders meeting of Takeda Pharmaceutical on December 5 and its agenda is about the firms acquisition of Shire. As commented
in the last paragraph of my essay we are very interested in whether Japanese and non-Japanese institutional shareholders will favor this action , while Japanese instituitional investors have 31% of the firms share and non-Japanese have 35 %.
in the last paragraph of my essay we are very interested in whether Japanese and non-Japanese institutional shareholders will favor this action , while Japanese instituitional investors have 31% of the firms share and non-Japanese have 35 %.
Search
Recent article
- Audit & Supervisory Board Member, etc. expected for Corporate Governance Reform
- Pay Attention to the Extraordinary Shareholders’ Meeting of Takeda Pharmaceutical
- An UK based fund management company challenges inexplicable shareholdings of a Japanese broadcasting giant
- A current movement on Japan’s Corporate Governance Code
- The current issues of Japanese Corporate Governance Reform
- Recent Evolution of Corporate Governance in Japan
- What is “Sodanyaku” ?
- Responsibility of Independent Directors – Toshiba’s case
- Toshiba’s undeniable tendency to cover-up
Calendar
RSS Feed
Contact
03-3539-3208
